RNRMarketResearch.com

“Continuous Renal Replacement Therapy Market” to 2022 - Led by “Company Profiles, Insights, Overview and Global Analysis”

Press Release   •   Jan 17, 2018 01:34 EST

Major players in Continuous Renal Replacement Therapy market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), and Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

Complete Report on Continuous Renal Replacement Therapy (CRRT) Market spread across 188 Pages, Profiling 15 Companies and Supported with 65 Tables and 51 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=425678 .

The global Continuous Renal Replacement Therapy market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market.

Competitive Landscape

1 Introduction

2 Visionary Leaders

3 Innovators

4 Dynamic Differentiators

5 Emerging Companies

6 Strength of Product Portfolio

7 Business Strategy Excellence

8 Competitive Intensity

9 Evaluation Parameters and Scores

10 Scoring Methodology

11 Competitive Intensity Score, By Company

Continuous Renal Replacement Therapy Market disposables segment further sub-segmented to the bloodline sets, hemofilters, & disposables (such as vascular access catheters and CRRT accessories, including drainage bags, ancillaries, stop cocks, syringes, & priming solutions). Hemofilters segment estimated to account for largest share of disposables market due to development of novel hemofilters and their increasing use in CRRT procedures.

Click Here For More Information with Discount on Continuous Renal Replacement Therapy Market with Top Company Profiles http://www.rnrmarketresearch.com/contacts/discount?rname=425678 .

Continuous Renal Replacement Therapy market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The The CVVH modality is estimated to account for the largest share of the global CRRT market owing to the wide adoption of this modality among healthcare providers.

Target Audience

  • CRRT manufacturers, suppliers, and distributors
  • CRRT service providers
  • Renal research laboratories
  • Renal associations and organizations
  • Hospitals and critical care units
  • Academic medical centers and universities
  • Business research and consulting service providers

Continuous Renal Replacement Therapy market based on product & modality. Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities & challenges in market for stakeholders and provides details of competitive landscape for market leaders. Furthermore, report analyzes micro markets with respect to their individual growth trends & prospects in total market.

Connect for More Details for Details and More Information “Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022” report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=425678 .

Geographically, Continuous Renal Replacement Therapy market segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific expected to register highest growth rate during forecast period, owing to large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.